S100A8 and acute coronary syndrome: In addition, increased levels of the serum S100A8 and S100A9 have been reported in diseases such as acute coronary syndrome, coronary artery calcification, cardiovascular intimal hyperplasia, and atherosclerosis (42), which have a strong association with dyslipidemia.